Improvement of adynamic bone disease after renal transplantation

Brazilian Journal of Medical and Biological Research

Volumn 39, Issue 1, 2006, Pages 31-41

  Abdallah, K A ^a   Jorgetti, V ^a   Pereira, R C ^a   dos Reis, L M ^a   Pereira, L M ^a   Correa P H S ^a   Borelli, A ^a   Ianhez, L E ^a   Moyses R M A ^a   David Neto, Elias ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adynamic bone disease; Aluminum bone disease; Bone biopsy; Parathormone; Renal osteodystrophy; Renal transplantation

Indexed keywords

25 HYDROXYVITAMIN D; ALUMINUM; ALUMINUM HYDROXIDE; CALCITRIOL; OSTEOCALCIN; PARATHYROID HORMONE;

ADULT; ADYNAMIC BONE DISEASE; ALUMINUM BONE LEVEL; ARTICLE; BONE BIOPSY; BONE DENSITY; BONE DISEASE; BONE MASS; BONE REMODELING; BONE TURNOVER; CLINICAL ARTICLE; FEMALE; FEMUR; HUMAN; HUMAN TISSUE; HYPOPARATHYROIDISM; KIDNEY TRANSPLANTATION; LUMBAR SPINE; MALE; MORPHOMETRICS; POSTOPERATIVE PERIOD; RENAL OSTEODYSTROPHY; TREATMENT OUTCOME;

EID: 30744457051     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006000100004     Document Type: Article

References (23)

1. Heaf JG (2003). Bone disease after renal transplantation. Transplantation, 75: 315-325.
2. Salusky IB & Goodman WG (2001). Adynamic renal osteodystrophy: Is there a problem? Journal of the American Society of Nophrology, 12: 1978-1985.
3. Julian BA, Laskow DA, Dubovisky J et al. (1991). Rapid loss of vertebral mineral density after renal transplantation. New England Journal of Medicine, 325: 544-550.
4. David-Neto E, Jorgetti V, Soeiro NM et al. (1993). Reversal of aluminum-related bone disease after renal transplantation. American Journal of Nephrology, 13: 12-17.
5. Cueto-Manzano AM, Konel S, Hutchison AJ et al. (1999). Bone loss in long-term renal transplantation: histopathology and densitometry analysis. Kidney International, 55: 2021-2029.
6. Rojas E, Carlini R, Clesca P et al. (2003). The pathogenesis of osteoodystrophy after renal transplantation as detected by early alterations in bone remodeling. Kidney international, 63: 1915-1923.
7. Jorgetfi V, Soeiro NM, Mendes V et al. (1994). Aluminium-related osteodystrophy and desterrioxamine treatment: role of phosphorus Nephrology, Dialysis, Transplantation, 9: 668-674.
8. Parfitt AM, Drezner MK, Glorieux FH et al. (1987). Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. Journal of Bone and Mineral Research, 2: 595-610.
9. Garcia-Carrasco M, Gruson M, de Vernejoul MC et al. (1988). Osteocalcin and bone morphometric parameters in adults without bone disease. Calcified Tissue international, 42: 13-17.
10. Melsen F & Mosekilde L (1978). Tetracycline double-labeling of iliac trabecular bone in 41 normal adults. Calcified Tissue Research, 26: 99-102.
11. Lo Cascio V, Kanis JA, Beneton MN et al. (1995). Acute effects of deflazacort and prednisone on rates of mineralization and bone formation. Calcffled Tissue International, 56: 109-112.
12. Cruz EAS, Lugon JR, Jorgetill V et al. (2003). Histologic evolution of bone disease 6 months after successful kidney transplantation. American Journal of Money Diseases, 44: 747-756.
13. Moshe L (2001). Post-transplant hypophosphatemia. Kidney International, 59: 2377-2387.
14. Bianchi ML, Colantonio G, Campanini F et al. (1994). CalGitriol and calcium carbonate therapy in early chronic renal failure. Nephrology, Dialysis, Transplantation, 9: 1595-1599.
15. Bover JA, Trinidad P, Rodriguez M at al. (1999). Dynamics of skeletal resistance to parathyroid hormone in the rat effect of renal failure and dietary phosphorus. Bone, 25: 279-285.
16. Casez JP, Lippuner K, Horber FF et al. (2002). Changes in bone mineral density over 18 months following kidney transplantation: the respective roles of prednisone and parathyroid hormone. Nephrology, Dialysis, Transplantation, 17: 1318-1326.
17. Ott SM, Maloney NA, Coburn JW et al. (1982). The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitdol therapy. Now England Journal of Medicine, 307: 709-713.
18. Torres A, Lorenzo V & Salido E (2002). Calcium metabolism and skeletal problems after transplantation. Journal of the American Society of Nephrology, 13: 551-558.
19. Weinstein RS, Jilka RL, Parfitt AM et al. (1998). Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteoclasts by glucocorticoids: Potential mechanisms of their deleterious effects on bone. Journal of Clinical Investigation, 102: 274-282.
20. Sprague SM (2000). Mechanism of transplantation-associated bone loss. Pediatfic Nephrology, 14: 650-653.
21. Faugere MC, Mewed H, Qi Q et al. (2000). High prevalence of low bone turnover and ocurrence of osteomalacia after kidney transplantation. Journal of the American Society of Nephrology, 11: 1093-1099.
22. Parker CR, Freemont AJ, Blackwell PJ et al. (1999). Cross-sectional analysis of renal transplantation osteoporosis. Journal of Bone and Mineral Research, 14: 1943-1951.
23. Coco M, Glicklich D, Faugere MC et al. (2003). Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. Journal of the American Society of Nephrology, 14: 2669-2676.